1-3 of 3
Xin Huang, PhD
Close
Sort by
Journal Articles

Response to Venetoclax in Combination with Low Intensity Therapy (LDAC or HMA) in Untreated Patients with Acute Myeloid Leukemia Patients with IDH, FLT3 and Other Mutations and Correlations with BCL2 Family Expression

Brenda J Chyla, PhD, Jason Harb, PhD, Christine Mantis, PhD, Jacob J Riehm, PhD, Jeremy A. Ross, PhD, Yan Sun, PhD, Xin Huang, PhD MD, Qi Jiang, PhD, Monique Dail, PhD, Franklin V. Peale, Jr., MD PhD, Jalaja Potluri, MD, John Hayslip
Journal: Blood
Blood (2019) 134 (Supplement_1): 546.
https://doi.org/10.1182/blood-2019-128373
Published: 2019
Journal Articles

The Combination Of 2-DG and Metformin Inhibits The mTORC1 Pathway and Suppresses Aggressive B Cell Lymphoma Growth and Survival

Chengfeng Bi, MD, PhD, Kai Fu, MD, PhD, Chunsun Jiang, PhD, Xin Huang, PhD, Wing Chung Chan, MD, Timothy McKeithan, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1665.
https://doi.org/10.1182/blood.V122.21.1665.1665
Published: 2013
Journal Articles

The Mir-17∼92 Cluster Activates mTORC1 Signaling in MCL by Targeting Multiple Regulators of the LKB1/AMPK/mTOR Pathway

Chengfeng Bi, MD, Chunsun Jiang, PhD, Xiaoxing Jiang, MD, Xin Huang, PhD, Mario R Fernandez, PhD, Javeed Iqbal, M. Sc, PhD, Robert E Lewis, PhD, Wing Chung Chan, MD, Timothy McKeithan, MD/PhD, Kai Fu, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 5118.
https://doi.org/10.1182/blood.V120.21.5118.5118
Published: 2012